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INTRODUCTION
Carcinosarcomas of the breast are otherwise known as 
metaplastic carcinoma. Its synonyms include biphasic 
metaplastic, metaplastic sarcomatoid carcinoma, and 
sarcomatoid carcinoma.[1] Metaplastic breast carcinomas 
(MBC) are rare primary breast malignancies.[2-6] They 
comprise less than 1% of invasive carcinomas of the 
breast.[2,6] They are characterized by the co-existence of 
carcinoma with sarcomatous elements.
They can be classified as monophasic spindle cell 
(sarcomatoid) carcinoma, biphasic carcinosarcoma, 
adenocarcinoma with divergent stromal differentiation 
(osseous, chondroid, and rarely rhabdoid) as well as 
adenosquamous and pure squamous cell carcinomas.[2,5]
These tumors are aggressive in nature as majority of them 
are triple negative for estrogen, progesterone, and Her-2 
neu receptor.[6,7] There is a paucity of information on 
clinically relevant pathologic features and clinical outcomes 
for these rare tumors.[5] In Indian literature, there are few 
case reports of this unusual tumor.[8]
Hereby, we report a case of carcinosarcoma of breast 
comprising duct cell carcinoma and angiosarcoma.
CASE REPORT
A 62-year-old female presented with complaint of pain and 
lump in left breast of 6 months duration. There was an ulcer 
present over nipple with discharge since 1 month. She had 
been operated for left breast swelling 3 years back, but no 
details were available. She had no history of abdominal 
pain or jaundice. There was no history of altered bowel and 
bladder habits. She is diabetic since last 4 years. She had no 
history of pulmonary tuberculosis. Her general examination 
was within normal limit.
She had a lump of size 10 × 10 cm occupying all the 
quadrants of left breast. There was destruction of nipple and 
areolar complex with ulceration of size 4 × 6 cm present at 
nipple areola area. Active discharge was noted. Her routine 
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A B S T R A C T
Carcinosarcomas comprise less than 1% of invasive carcinomas of the breast. They are a heterogeneous group of malignant 
tumors in which part or all of the carcinomatous epithelium is transformed into a nonglandular component by metaplastic 
growth process. We report a case of carcinosarcoma of breast. She was a 62‑year‑old female who presented with complaint of 
pain and lump in left breast of 6 months duration. There was a discharging ulcer measuring 4 ×6 cm over the nipple of 1‑month 
duration. Computed tomography of chest and positron emission tomography report was suggestive of carcinoma of left breast 
with left axillary lymphadenopathy and lung metastasis. Histopathology of the tumor was reported as infiltrating duct cell 
carcinoma (IDC) with angiosarcoma. The IDC was estrogen and progesterone receptor negative and Human Epidermal Growth 
Factor ‑2 receptor positive. The angiosarcoma was positive for vimentin, vascular endothelial growth factor, CD34, and CD31. 
The Ki‑67 labeling index was 60% and the epidermal growth factor receptor was positive. This is a case of carcinosarcoma of 
breast adding to the existing literature.
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investigations were within normal limit. She was reactive 
for HBs Ag.
Mammogram revealed a large hypoechoic lesion in the 
left breast with multiple enlarged axillary lymphnodes. 
Computed tomography (CT) chest report was suggestive 
of carcinoma left breast with left axillary lymphadenopathy 
and lung metastasis.
Histopathology of the biopsy suggested the possibility of 
duct cell carcinoma and sarcoma. Immunomarkers favored 
a tumor of mesenchymal origin.
In bone scan report, there was no evidence of 
osteoblastically active metastatic bone deposits. Positron 
emission tomography (PET) report showed a primary 
malignant lesion in left breast with ipsilateral left axillary 
node [Figure 1]. There was presence of lung metastasis. The 
stage of the patient was T4N2M1.
Left simple mastectomy was done for this patient. 
Intraoperatively, the swelling was of size 10 × 8 cm with 
ulceration of overlying skin, occupying almost all quadrants 
of left breast. The gross specimen of the mastectomy 
showed skin ulceration. Beneath this ulcerated area, there 
was a blackish lesion measuring 8 × 6 cms, also seen was a 
whitish lesion measuring 2 × 1 cms [Figure 2].
Histopathogically, there was an ulcerated area. Beneath 
the ulcerated area were granulation tissue and the tumor 
components. The tumor components were admixed with 
each other. One was infiltrating duct cell carcinoma (not 
otherwise specified) and the other was a mesenchymal 
component. [Figures 3 and 4] The duct cell carcinoma was 
of low-grade type. The sarcomatous component comprised 
many poorly formed vascular channels and presence of 
bizarre hyperchromatic tumor giant cells (angiosarcoma). 
The basal resected margin of the specimen was free 
of tumor. According to World Health Organization 
classification of breast tumors, it was diagnosed as 
metaplastic carcinoma of breast (carcinosarcoma).[9] 
The adenocarcinomatous component was negative for 
estrogen and progesterone receptors. However, it 
showed positivity for Her-2 receptor. [Figure 5] The 
sarcomatous areas showed diffuse positivity for vimentin 
and vascular endothelial growth factor (VEGF). The giant 
cells in the sarcomatous area also showed positivity for 
CD34 and CD31. [Figure 6] Based on the morphologic and 
immunohistochemical findings, the tumor was diagnosed 
as metaplastic carcinoma of breast. The Ki-67 labeling 
index was 60% and the tumor showed intense epidermal 
growth factor receptor (EGFR) positivity.
Currently the patient is under follow-up.
DISCUSSION
Carcinosarcoma of breast is a rare malignancy. It is 
characterized by co-existence of two distinct cell lines 
described as a breast carcinoma of ductal type with a 
sarcoma-like component.[1] These tumors pose a diagnostic 
and therapeutic challenge owing to their rarity.[10]
The present case histopathologically showed a combination 
of IDC and angiosarcoma.
Carcinosarcoma breast usually presents as painful large 
lump in breast. There is no preference for any particular 
age-group. Their clinical features are usually similar tothat 
of patients with IDC.[6]
The present case was an elderly female who presented with 
a large, ulcerated breast lump.
The exact cell of origin of these tumors is not known. 
According to several theories, these tumors are of 
myoepithelial origin with presence of both carcinomatous 
and sarcomatous features on histopathology.[6,11]
Yamaguchi R et al. in their study have opined that the 
presence of high-grade spindle cells in metaplastic breast 
carcinoma may indicate aggressive behavior.[3] One recent 
study has concluded that the prognosis of metaplastic 
breast carcinoma is poorer than for both invasive ductal 
carcinoma and triple negative invasive ductal carcinoma. 
The poor prognostic factors are tumor size larger than 
5.0	cm,	lymph	node	involvement,	and	Ki-67	≥14%.[12]
The present tumor showed high Ki -67 labeling index.
Immunohistochemistry plays an important rolein the 
diagnosis of carcinosarcomas. Usually in carcinosarcoma 
breast, reactivity for both keratinand vimentin is observed.[6] 
Majority of metaplastic carcinomas express EGFR and may 
serve as a potential therapeutic target for EGFR inhibitors.[1]
The present tumor expressed cytokeratin and vimentin in 
the carcinomatous and sarcomatous areas, respectively. It 
was negative for estrogen receptor (ER) and progesterone 
receptor (PR). However, it showed positivity for Her-2 
receptor in the duct cell carcinomatous area. We have not 
done - Fluorescence in situ hybridization (FISH) for human 
epidermal growth factor -2 (Her-2). The tumor also showed 
intense positivity for EGFR.
One study reported 98 patients with carcinosarcoma 
breast through the surveillance, epidemiology, and end 
results  (SEER) database and concluded that these are 
aggressive, treatment refractory tumors with shared clinical 
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features and outcomes similar to poorly differentiated, 
receptor-negative adenocarcinoma of the breast. They 
metastasize via lymphatics and bloodstream.[6,13]
In general, the recommended treatment options are similar 
to that of treatment of patients with invasive breast cancer. 
In the majority of the reported cases, mastectomy with or 
without axillary lymph node dissection was performed, 
followed by postoperative chemotherapy and radiation 
therapy.[6,14] Kim et al. have reported that patients who were 
treated with neoadjuvant or adjuvant anthracycline-based 
chemotherapy showed a better clinical outcome compared 
to those treated with cyclophosphamide, methotrexate, 
5-fluorouracil (CMF) and the neoadjuvant chemotherapy 
for carcinosarcoma breast was less effective than for 
conventional adenocarcinoma.[6,15]
Different authors have suggested the 5-year overall survival 
rate of carcinosarcoma ranging from 49-68%.[6,16]
The differential diagnosis of metaplastic carcinomas includes 
both neoplastic and non-neoplastic lesion. Metaplastic 
Figure 1: Whole body 18FDG PET /CT scan (a) Sagittal, (b) Transverse and (c) Coronal sections, showing a heterogeneous soft tissue density mass lesion 
measuring (9.5 x 8.0 x 10.0 Cms) in size, involving inferior, outer quadrant of left breast, associated with thickening of overlying skin and infiltration of 
pectoralis major muscle. Intensely increased Fluorodeoxyglucose (FDG) uptake noted in this mass lesion with max standardized uptake value (SUV): 
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carcinomas with bland spindle cell should be distinguished 
from exuberant scars, fibromatosis, and nodular fasciitis 
and, more infrequently, from myofibroblastomas, 
pseudoangiomatous stromal hyperplasia, and acute and 
chronic abscess with fat necrosis. Metaplastic carcinomas 
with significant atypia must be distinguished from 
malignant phyllodes tumor and primary or metastatic 
sarcoma.[1]
Breast carcinosarcomas are rare and have nonspecific 
clinical and radiological features. Usually the postoperative 
pathology helps in the final diagnosis.[16]
The positive expression of ER/PR and HER-2 in breast 
carcinosarcoma is low. Since majority of them express 
EGFR, further study is required for possible new therapeutic 
target.[17]
This present case is an additional case of metaplastic 
carcinoma of the breast to the existing literature, 
emphasizing study of the histopathological specimen to 
arrive at a proper diagnosis.
Figure 3: Histopathology of duct cell carcinoma (arrow) and angiosarcoma 
(hematoxylin and eosin, ×40)
Figure 4: Histopathology of angiosarcoma showing poorly formed 
vascular channels (hematoxylin and eosin, ×40)
Figure 5: ER, PR negativity, and Her‑2 positivity in duct cell carcinomatous 
area (Immunohistochemistry, ×40)
Figure 6: CD 34 and CD31 positivity in the sarcomatous area and negative 
in the duct cell carcinomatous area (IHC, ×40)
Figure 2: Cut section of the simple mastectomy specimen showing 
ulceration and the blackish lesion (angiosarcoma, white arrow) and the 
whitish lesion (duct cell carcinoma, blue arrow)
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